ZimVie Inc. Common Stock (ZIMV)
ZimVie Inc. is a global developer and manufacturer of dental and musculoskeletal implant solutions, including products for dental implantology, spine, and trauma care. The company focuses on innovation and advanced technologies to improve patient outcomes across its healthcare segments.
Company News
ZimVie Inc. has been fully acquired by ARCHIMED, an investment firm focused on healthcare industries. The transaction was completed at $19.00 per share, resulting in ZimVie being delisted from NASDAQ.
ZimVie Inc. has been fully acquired by ARCHIMED for $19.00 per share, delisting the company from NASDAQ. The transaction represents a strategic move in the dental implant market.
ZIMV earnings call for the period ending March 31, 2024.
MacroGenics (MGNX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.